showed a trendp = 0.021
The non-randomized DAART trial (directional atherectomy and anti-restenotic therapy vs drug-coated balloon alone in the popliteal) showed a trend towards increased 12 month primary patency (82% versus 65%, p = 0.021) for the DAART arm (Stavroulakis et al., 2017 ), however aneurysmal dilatation was seen more often after DAART (although this was not statistically significant).